Regeneron остается в числе фаворитов после квартального отчета Финам.RU - 07 Nov 2023 Regeneron остается в числе фаворитов после квартального отчета ... More
Regeneron и J&J получат 1,4 млрд долл. для разработки новых вакцин против COVID-19 Фармацевтический вестник - 23 Aug 2023 Regeneron и J&J получат 1,4 млрд долл. для разработки новых вакцин против COVID-19 ... More
"Коктейль антител" от Regeneron оказался менее эффективным против "омикрона" Интерфакс - 16 Dec 2021 "Коктейль антител" от Regeneron оказался менее эффективным против "омикрона" ... More
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth Reuters - 25 Apr 2024 Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth ... More
Regeneron signs Mammoth gene editing deal worth $100M upfront Fierce Biotech - 25 Apr 2024 Regeneron signs Mammoth gene editing deal worth $100M upfront ... More
Regeneron and Mammoth announce gene editing partnership worth $370m per target PMLiVE - 26 Apr 2024 Regeneron and Mammoth announce gene editing partnership worth $370m per target ... More
Regeneron, Mammoth Launch In Vivo CRISPR Gene Editing Collaboration Genetic Engineering & Biotechnology News - 25 Apr 2024 Regeneron, Mammoth Launch In Vivo CRISPR Gene Editing Collaboration ... More
Sales of Roche's juggernaut Vabysmo rout the analyst consensus Fierce Pharma - 24 Apr 2024 Sales of Roche's juggernaut Vabysmo rout the analyst consensus ... More
Regeneron and Mammoth team up to develop gene editing therapies Pharmaceutical Technology - 26 Apr 2024 Regeneron and Mammoth team up to develop gene editing therapies ... More
AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study XM - 25 Apr 2024 AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study ... More
Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors MarketWatch - 26 Apr 2024 Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors ... More
Regeneron Bets $100M That Mammoth’s CRISPR Tech Can Deliver on Next Wave of Genetic Medicines MedCity News - 25 Apr 2024 Regeneron Bets $100M That Mammoth’s CRISPR Tech Can Deliver on Next Wave of Genetic Medicines ... More
Regeneron inks $100M deal to develop gene-editing therapies Crain's New York Business - 26 Apr 2024 Regeneron inks $100M deal to develop gene-editing therapies ... More
Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery BioSpace - 25 Apr 2024 Regeneron Pays Mammoth $100M to Access CRISPR Enzymes for AAV Delivery ... More
Regeneron (REGN) Reports Next Week: What You Should Expect Yahoo Finance - 25 Apr 2024 Regeneron (REGN) Reports Next Week: What You Should Expect ... More
Regeneron Fails to Quash Skin Cancer Drug Warning Suit (Correct) Bloomberg Law - 26 Apr 2024 Regeneron Fails to Quash Skin Cancer Drug Warning Suit (Correct) ... More
Regeneron Pharmaceuticals достойна внимания инвесторов — Финам.Ру Финам.RU - 12 May 2022 Regeneron Pharmaceuticals достойна внимания инвесторов — Финам.Ру ... More
Head-to-head, it's AbbVie's Rinvoq over Regeneron's Dupixent Fierce Pharma - 26 Apr 2024 Head-to-head, it's AbbVie's Rinvoq over Regeneron's Dupixent ... More
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study Reuters - 25 Apr 2024 AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study ... More